Navigation Links
Dasatinib Shows High Early Response Rate as First Treatment for,Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report

CHICAGO, June 2, 2007 - An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.

"Patients taking dasatinib achieve complete cytogenetic response - absence of the mutated protein that drives this disease - more rapidly than we've observed historically using the current front-line therapy. Side effects are very manageable," says Ehab L. Atallah, M.D., lead author of the study and a fellow in M. D. Anderson's Department of Leukemia. Atallah presented study results at the annual meeting of the American Society of Clinical Oncology in Chicago Saturday June 2nd, 2007. The clinical trial remains in progress with 35 patients enrolled.

Dasatinib, known commercially as Sprycel and produced by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration a year ago for use by patients whose disease is unresponsive to or becomes resistant to the front-line therapy imatinib. Both drugs bind to and block a genetically flawed protein known as BCR-ABL, which causes the disease. Atallah explains that dasatinib binds to both forms BCR-ABL while imatinib blocks only one.

"Our hypothesis is that treating with dasatinib first will produce an earlier response, which may translate to a better overall survival," Atallah says. "We haven't proved that here, but these early results are encouraging."

Atallah and colleagues evaluated 35 patients who enrolled in the clinical trial between November 2005 and December 2006. Patients receive either 100 mg of dasatinib once daily or 50 mg twice daily.

Thirty four patients had been on the clinical trial for at least three months when Atallah and lead researcher Jorge Cortes, M.D., professor in the Department of Leukemia, eva
'"/>




Page: 1 2 3

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
(Date:5/23/2013)... BEDFORD, Mass. , May 23, 2013 /PRNewswire/ ... HOLX ), a leading developer, manufacturer and ... surgical products, with an emphasis on serving the ... first large-scale observational study in a U.S. clinical ... mammography technology (breast tomosynthesis) with conventional 2D mammography ...
(Date:5/23/2013)...  Ameritox, the nation,s leader in pain medication ... to become part of its Urine Drug Monitoring ... and improve the clinical outcomes for injured workers. ... manager in the workers, compensation industry, has used ... management strategy for several years. By establishing a ...
Breaking Medicine Technology:Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3
... Amgen (Nasdaq: AMGN ) will participate in ... the St. Regis New York in New York City, beginning ... president of Global Development, for Amgen, will present at the ... the Internet and can be accessed from Amgen,s website, ...
... Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: ... it has filed a Supplemental Biologics License Application (sBLA) with ... Intradermal (Influenza Virus Vaccine).  The file has been accepted ... the first half of 2011. "Upon FDA ...
Cached Medicine Technology:FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 2FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 3FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 4
(Date:5/24/2013)... May 24, 2013 Wednesday, 15th May 2013 ... , Register to access webinar playback: http://bit.ly/10Rt0ZH , ... the financial markets. Across the globe and particularly in Europe, ... affect M&A activity . For dealmakers, understanding how the ... the ‘Tobin Tax’ affects your corner of the market will ...
(Date:5/24/2013)... 2013 IMED Mobility, a premier provider of ... Nashville recording artist Michelle Murray on Thursday, June 20th 2 p.m ... Finish Line” music and movie tour, which shares the story of ... on the track in 2000. Much of the film takes place ... the sport of INDYCAR racing despite suffering a crash that left ...
(Date:5/23/2013)... (PRWEB) May 24, 2013 Sublime ... Cellulite Whisperer line, with a 35% ... Summer Sale" includes two proprietary products, the ... Lotion . , Purchasers receive a report "Getting ... "The Gel has a wonderful grapefruit scent," says ...
(Date:5/23/2013)... The sodium theory has been ... Katz in the early 1950s, after their experiments on ... and potassium ions in nerve functions . Since ... have known amazing developments. In The Sodium Theory Revisited, ... account of the latest developments in the field since ...
(Date:5/23/2013)... CT (PRWEB) May 23, 2013 ... satisfaction and perception management tools, and ASCA, the ... develop the new ASCA Benchmarking Program. Voyance ... surveying technology and national benchmarking experience to support ... a comprehensive, state-of-the-art benchmarking tool. , “Voyance is ...
Breaking Medicine News(10 mins):Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:Local Mobility Dealer Hosts Nashville Recording Artist 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3
... cholesterol also control hypertension. // ,Researchers at Warwick ... using statins to reduce cholesterol get a bonus benefit from ... on blood pressure levels too. ,The researchers ... in blood pressure. The overall effect of the use of ...
... cases among the inmates of Tihar Jail in the national ... official report// said here Thursday. ,In 2006, 36 ... 12 in 2002, Minister of State for Home Affairs S. ... that regular health screening camps are being organised by the ...
... problem that has been long overlooked, President A.P.J. Abdul Kalam ... mentally ill women// who have no home. ,"While ... for themselves but also for their families, it becomes critical ... at the beginning of a two-day conference "Mental health - ...
... reminder of the penetration of kidney diseases worldwide. According to ... throes of kidney related ailments. ,Reputed nephrologists emphasized, ... detect the disease early. Kidney transplant and dialysis is simply ... ,Uncomplicated urine tests and blood tests can ...
... A new survey confirms that pulmonary/critical care physicians ... actively managing// their patients’ sleep problems. The survey ... Institute (ACCP-SI). It was found that most pulmonary/critical ... patterns of their female patients and are advising ...
... AMA has written to Health Minister, Tony Abbott, urging ... include funding guarantees// and performance benchmarks for medical training ... (AHCA) negotiations. ,The current AHCA expires ... soon. ,AMA President, Dr Mukesh Haikerwal, ...
Cached Medicine News:Health News:Nearly 2,500 Mentally Ill Women in Delhi are Destitute: Abdul Kalam 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3
... delivers the performance and reliability ... management systems. As the industry ... set the benchmark. When it ... performance and technological longevity, Heartlab's ...
... first digital solution designed specifically for cardiologists ... outside cardiology. From the server core to ... combined expertise in both cine film and ... work the way they want, wherever they ...
Precision near-field imaging combined with the best handling IVUS catheter....
... Medison SonoAce 9900 is ... based ultrasound system, with ... is DICOM compatible, designed ... general imaging, obstetrics, gynecology, ...
Medicine Products: